Clinical Relapse After Cessation of Tenofovir Therapy in Hepatitis B e Antigen–Negative Patients
Wen‐Juei Jeng(Chang Gung Memorial Hospital), Yun‐Fan Liaw(Chang Gung Memorial Hospital), Tsung‐Hui Hu(National Sun Yat-sen University), Yi‐Cheng Chen(Chang Gung University), I‐Shyan Sheen(Chang Gung University), Chih‐Lang Lin(Keelung Chang Gung Memorial Hospital), Rong‐Nan Chien(Chang Gung Memorial Hospital)
Cited by 91
Related Papers
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
|Hepatology International|2008|870
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
|JNCI Journal of the National Cancer Institute|2005|569
Hepatogastroenterology
|Hepatogastroenterology|2012|536
Epidemiological characteristics and risk factors of hepatocellular carcinoma
|Journal of Gastroenterology and Hepatology|1997|473